In 2024, the incidence of Tuberculosis in China, including HIV-positive cases, is forecasted to increase from the previous actual data point in 2023. By 2025, the incidence is projected to rise by approximately 3.3%, continuing this upward trajectory through to 2028, reaching an even higher incidence rate. Over the forecast period from 2024 to 2028, the Compound Annual Growth Rate (CAGR) indicates steady growth in cases. This reflects a concerning trend of rising incidence, potentially influenced by factors such as public health policies, healthcare access, and socio-economic conditions.
Future trends to watch for include the impact of new healthcare initiatives, innovations in TB treatment and prevention, and possible socio-economic changes that could alter the incidence trajectory. Monitoring these factors will be critical in evaluating the accuracy of forecasts and adapting strategies to combat TB effectively.
